May 5 (Reuters) - Maravai LifeSciences Holdings Inc
MRVI.O :
* MARAVAI LIFESCIENCES REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
* Q1 REVENUE ROSE 65 PERCENT TO $244.3 MILLION
* CONTINUES TO PROJECT TOTAL REVENUE FOR 2022 IN RANGE OF
$920.0
MILLION TO $960.0 MILLION
* ADJUSTED FULLY DILUTED EPS (NON-GAAP) IS NOW EXPECTED TO
BE IN
RANGE OF $1.74 - $1.90 PER SHARE FOR 2022
* FY2022 EARNINGS PER SHARE VIEW $1.77, REVENUE VIEW $942.1
MILLION -- REFINITIV IBES DATA
* Q1 REVENUE VIEW $232.3 MILLION -- REFINITIV IBES DATA
* QTRLY ADJUSTED FULLY DILUTED EPS $0.54
* Q1 EARNINGS PER SHARE VIEW $0.44 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX5yP3MD
Further company coverage: MRVI.O
((Reuters.Briefs@thomsonreuters.com;))